Community Health Systems Inc Dossier - Source-backed chat

Community Health Systems Inc

CYHNYSE

SectorHealth Care

IndustryHealth Care Facilities

Beta (adjusted)1.56

Intrinsic Value

No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference.

Market Price $2.75Price as of 1 Oct 2026

Data confidence Sign in to view data confidence

Market Cap $387.8M

Enterprise Value $9.8B

Shares Outstanding 136.7M diluted

Moat Rating Wide

Next Earnings Date22 Oct 2026

Last ex-dividend13 Dec 2012

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Community Health Systems (CYH) is in a transitional turnaround phase. While the company has successfully executed selective hospital divestitures to improve its liquidity profile and pay down its massive debt load, it continues to face significant operational headwinds. These include elevated labor costs, persistent medical supply inflation, and high insurance claim denial rates. Although the company returned to positive net income in FY2025, Q1 2026 results showed a wider-than-expected net loss and declining patient volumes. A 'Hold' recommendation is warranted as the market waits to see if strategic divestitures and cost-saving measures can drive sustainable margin expansion and deleveraging.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets7 analysts · as of 18 Aug 2026

Low · most bearish analyst$2.00

Mean target$3.39

High · most bullish analyst$5.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

Persistent labor inflation, worsening payer mix, and elevated insurance claim denials compress margins. If patient volumes continue to decline and the company fails to execute planned divestitures at favorable valuations, liquidity concerns could resurface, putting downward pressure on the stock.

Base CaseCentral scenario

The company continues its strategy of regional portfolio optimization, using divestiture proceeds to pay down near-term debt maturities. Operating margins stabilize around 12% to 12.5% as contract labor costs moderate, and revenue remains flat to slightly down due to the impact of sold facilities.

Bull CaseUpside scenario

Community Health Systems is actively executing a portfolio rationalization strategy, divesting underperforming or non-core hospitals to generate significant cash proceeds (targeting over $1.2 billion in 2026) to pay down its substantial debt burden. Simultaneously, the company is focusing capital on core markets and expanding high-margin outpatient services and capacity. Operational efficiency is expected to improve through the implementation of a new ERP system (targeting $30 million to $50 million in savings in 2026) and the integration of AI applications in clinical care and revenue cycle management.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Active portfolio optimization through strategic divestitures of non-core or lower-margin hospitals, which has significantly improved cash positions.
Successful execution of debt refinancing and early redemption of high-interest notes, reducing near-term default risk.
Strong market presence as a leading operator of general acute care hospitals in non-urban and suburban markets with limited direct competition.

Key Investment Risks

Highly leveraged capital structure with over $10 billion in long-term debt and negative shareholder equity.
Operational headwinds from elevated labor costs, medical specialist fees, and persistent inflation in medical supplies.
Exposure to government reimbursement policy changes (Medicare/Medicaid) and rising commercial insurance claim denial rates.

Thesis Invalidation Triggers

Failure to complete planned hospital divestitures or receiving significantly lower-than-expected valuations for sold assets.
A material increase in contract labor costs or medical supply expenses that severely compresses EBITDA margins.
Inability to refinance upcoming debt maturities on manageable terms, leading to increased risk of distressed exchanges.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.